St. Jude Children Research Hospital
Memphis, Tennessee, 38105, United States
NCT Number: NCT00075101
The purpose of this study is to determine the relationship between dexamethosone (steroid) and children's sleep and fatigue.
Looking for future studies?
Notify Me5 year–21 year
All sexes
Interventional
Phase 3
Memphis, Tennessee, 38105, United States
Approximately 134 children and adolescents will be enrolled. All children and adolescents will wear a wrist actigraph for two consecutive 5-day study periods. Children and adolescents will have blood drawn 2 times on Day 1 when they are on dexamethosone. Their parents will complete a sleep diary and fatigue questionnaire by telephone on Days 2 and 5 of both study periods.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Children and adolescents with Leukemia, both genders
10 day study cycle: 5 day observation pre-steroid,5 day observation post-steroid
Other names: Mestinon
Time frame: 10 days
Time frame: 5 days
Time frame: 5 days
National Institute of Nursing Research (NINR)
Nih
Sleep, Fatigue, and Dexamethosone in Childhood Cancer
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT00400946
Chemically-Induced Disorders, Drug-Related Side Effects and Adverse Reactions
Boston, Massachusetts, United States
View Trial DetailsNCT00342888
Hematologic Diseases, Hemic and Lymphatic Diseases
Berkeley, California, United States
View Trial DetailsNCT02158858
Blood Coagulation Disorders, Blood Platelet Disorders
Phoenix, Arizona, United States
View Trial DetailsNCT06704243
Cancer, Hematologic Diseases
Toronto, Ontario, Canada
View Trial Details